Joseph J. Stephenson

1.6k total citations
13 papers, 888 citations indexed

About

Joseph J. Stephenson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Joseph J. Stephenson has authored 13 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Cancer Research. Recurrent topics in Joseph J. Stephenson's work include Acute Myeloid Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Joseph J. Stephenson is often cited by papers focused on Acute Myeloid Leukemia Research (2 papers), Cancer Treatment and Pharmacology (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Joseph J. Stephenson collaborates with scholars based in United States, France and Netherlands. Joseph J. Stephenson's co-authors include Daniel D. Von Hoff, Susan B. Brown, William Sutherland, Robert Penny, Mitesh J. Borad, Cristian Fernández, Stephen P. Anthony, Donald Richards, David Loesch and Peter J. Rosen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Joseph J. Stephenson

12 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph J. Stephenson United States 8 426 340 326 275 162 13 888
Beth A. Hellerstedt United States 14 557 1.3× 316 0.9× 267 0.8× 314 1.1× 96 0.6× 32 1.0k
H Sawada Japan 15 503 1.2× 404 1.2× 187 0.6× 669 2.4× 88 0.5× 39 1.3k
Elisabetta Pietri Italy 15 593 1.4× 200 0.6× 364 1.1× 320 1.2× 87 0.5× 27 909
Andreas Kaubisch United States 18 584 1.4× 161 0.5× 129 0.4× 498 1.8× 171 1.1× 66 1.3k
Masahiro Kashiwaba Japan 16 877 2.1× 166 0.5× 236 0.7× 642 2.3× 163 1.0× 46 1.7k
Hiroomi Tada United States 9 537 1.3× 397 1.2× 146 0.4× 365 1.3× 58 0.4× 13 951
Herman Bril Netherlands 18 439 1.0× 159 0.5× 161 0.5× 312 1.1× 92 0.6× 56 1.1k
Ladan Fazlollahi United States 9 324 0.8× 269 0.8× 373 1.1× 395 1.4× 34 0.2× 21 1.2k
Sheryl K. Elkin United States 15 498 1.2× 446 1.3× 280 0.9× 817 3.0× 67 0.4× 22 1.5k

Countries citing papers authored by Joseph J. Stephenson

Since Specialization
Citations

This map shows the geographic impact of Joseph J. Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Stephenson more than expected).

Fields of papers citing papers by Joseph J. Stephenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Stephenson. The network helps show where Joseph J. Stephenson may publish in the future.

Co-authorship network of co-authors of Joseph J. Stephenson

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Stephenson. A scholar is included among the top collaborators of Joseph J. Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Stephenson. Joseph J. Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Montgomery, Bruce, Mario A. Eisenberger, Matthew B. Rettig, et al.. (2015). Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer. Clinical Cancer Research. 22(6). 1356–1363. 64 indexed citations
2.
Tan, Antoinette R., Darlene Gibbon, Mark N. Stein, et al.. (2013). Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 71(6). 1635–1643. 90 indexed citations
3.
Burke, James M., Donald L. Lamm, Maxwell V. Meng, et al.. (2012). A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer. The Journal of Urology. 188(6). 2391–2397. 191 indexed citations
4.
Hoff, Daniel D. Von, Joseph J. Stephenson, Peter J. Rosen, et al.. (2010). Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers. Journal of Clinical Oncology. 28(33). 4877–4883. 434 indexed citations
5.
Raza, Azra, Joseph G. Jurcic, Gail J. Roboz, et al.. (2009). Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial. Leukemia & lymphoma. 50(8). 1336–1344. 49 indexed citations
6.
Samlowski, Wolfram E., Jeffrey S. Weber, R. Gonzalez, et al.. (2008). Phase I/II study of imexon (AMP) plus dacarbazine (DTIC) in patients (Pts) with metastatic malignant melanoma. Journal of Clinical Oncology. 26(15_suppl). 9066–9066. 1 indexed citations
7.
Schreeder, Marshall T., Robert A. Figlin, Joseph J. Stephenson, et al.. (2008). Phase I multicenter trial of perifosine in combination with sorafenib for patients with advanced cancers including renal cell carcinoma. Journal of Clinical Oncology. 26(15_suppl). 16024–16024. 11 indexed citations
8.
Stephenson, Joseph J., Nicole Lewis, Jennifer C. Martin, et al.. (2008). Phase I multicenter study to assess the safety, tolerability, and pharmacokinetics of AZD4877 administered twice weekly in adult patients with advanced solid malignancies. Journal of Clinical Oncology. 26(15_suppl). 2516–2516. 7 indexed citations
9.
10.
11.
Gribben, JG, Joseph J. Stephenson, Nancy L. Bartlett, et al.. (2005). A phase II study of Xcellerated T Cells in patients with relapsed or refractory indolent non-Hodgkin’s lymphoma (NHL). Journal of Clinical Oncology. 23(16_suppl). 2510–2510. 1 indexed citations
12.
Vukelja, Svetislava J., et al.. (1998). High-Dose Taxol, Cyclophosphamide, and Cisplatin with Stem Cell Support in the Treatment of Metastatic Breast Cancer. The Breast Journal. 4(3). 165–170.
13.
Fitzpatrick, J. M., A. R. Constable, Thomas Sherwood, et al.. (1978). Serial Bone Scanning: The Assessment of Treatment Response in Carcinoma of the Prostate. British Journal of Urology. 50(7). 555–561. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beth A. Hellerstedt Breakdown of academic impact, for papers by H Sawada Breakdown of academic impact, for papers by Elisabetta Pietri Breakdown of academic impact, for papers by Andreas Kaubisch Breakdown of academic impact, for papers by Masahiro Kashiwaba Breakdown of academic impact, for papers by Hiroomi Tada Breakdown of academic impact, for papers by Herman Bril Breakdown of academic impact, for papers by Ladan Fazlollahi Breakdown of academic impact, for papers by Sheryl K. Elkin
Rankless by CCL
2026